The estimated Net Worth of Robin Hughes is at least $1.66 Миллион dollars as of 20 March 2014. Robin Hughes owns over 23,253 units of Staar Surgical Co stock worth over $593,318 and over the last 17 years Robin sold STAA stock worth over $1,063,075.
Robin has made over 8 trades of the Staar Surgical Co stock since 2008, according to the Form 4 filled with the SEC. Most recently Robin sold 23,253 units of STAA stock worth $367,862 on 20 March 2014.
The largest trade Robin's ever made was buying 50,000 units of Staar Surgical Co stock on 9 May 2008 worth over $138,000. On average, Robin trades about 6,646 units every 107 days since 2007. As of 20 March 2014 Robin still owns at least 19,575 units of Staar Surgical Co stock.
You can see the complete history of Robin Hughes stock trades at the bottom of the page.
Robin's mailing address filed with the SEC is 1911 WALKER AVE, , MONROVIA, CA, 91016.
Over the last 21 years, insiders at Staar Surgical Co have traded over $305,974,767 worth of Staar Surgical Co stock and bought 10,576,326 units worth $122,359,752 . The most active insiders traders include Partners, L.P.Broadwood Cap..., Partners, L.P.Bradsher Neal... и Gilbert H Kliman. On average, Staar Surgical Co executives and independent directors trade stock every 26 days with the average trade being worth of $1,643,742. The most recent stock trade was executed by Arthur C Butcher on 12 August 2024, trading 1,315 units of STAA stock currently worth $49,957.
staar surgical company (nasdaq: staa), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye has been dedicated solely to ophthalmic surgery for over 30 years. the company offers the evo visian implantable collamer® lenses (icls) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and hyperopic icl, which treats far-sightedness. these lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. all of these lenses are foldable, which permits the surgeon to insert them through a small incision. staar's lens used in refractive surgery is called an implantable collamer lens or "icl". nearly 600,000 visian icls have been implanted to date. it also provides minimally invasive intraocular lenses (iols), including foldable iols for use in minimally invasive cataract surgical procedures; aspheric iols that produce a clearer image than trad
Staar Surgical Co executives and other stock owners filed with the SEC include: